Fig. 7From: Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapyThe relationship between programmed cell death and MAFLD. Inhibiting relevant targets in the apoptosis, ferroptosis and pyroptosis pathways may have therapeutic effects on MAFLD. In addition, there are various research results on targeting necroptosis and autophagy for treatment of MAFLD. Further research is neededBack to article page